was reduced. Spironolactone has been found to be an independent risk factor for bullous pemphigoid, a disease which occurs more commonly in the elderly including those living in the long term care setting. Unfortunately, drug-induced bullous pemphigoid may not resolve after drug withdrawal as in case #2 above. Although bullous pemphigoid may be associated with spironolactone use in rare cases, spironolactone is an effective treatment of PA as in both of the cases above. In all hypertensive nursing home patients (resistant hypertension, or hypertension with hypokalemia), a diagnosis of primary aldosteronism should be considered because recognition and treatment offers the potential to reduce polypharmacy and cardiovascular morbidity. Author Disclosures: All authors have stated there are no disclosures to be made that are pertinent to this abstract.
Read full abstract